Cargando…
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes: first report of a new diagnostic and clinical challenge
IgA plasma cell myeloma (PCM) has been linked to molecular abnormalities that confer a higher risk for adverse patient outcomes. However, since IgA PCM only accounts for approximately 20% of all PCM, there are very few reports on high-risk IgA PCM. Moreover, no such reports are found on the more inf...
Autores principales: | Monroig-Rivera, Carlos A., Cruz, Clara N. Finch |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028011/ https://www.ncbi.nlm.nih.gov/pubmed/36950814 http://dx.doi.org/10.4132/jptm.2023.02.07 |
Ejemplares similares
-
Biclonal myeloma in renal failure
por: NIKOLOVA-VLAHOVA, MILENA K., et al.
Publicado: (2020) -
Biclonal IgD and IgM Plasma Cell Myeloma: A Report of Two Cases and a Literature Review
por: Chen, Zhongchuan W., et al.
Publicado: (2013) -
Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer
por: Kim, Nae Yu, et al.
Publicado: (2011) -
Cutaneous Vasculitis: An Unusual Presentation of a Biclonal Nodal Plasma Cell Dyscrasia
por: Swan, D., et al.
Publicado: (2017) -
Immunoglobulin D-λ/λ biclonal multiple myeloma: A case report
por: He, Qiao-Ling, et al.
Publicado: (2021)